Most RA Patients Meet EMA's JAK Inhibitor Warning Criteria
Recent regulatory warnings could mean that four in five patients with RA may not be prescribed JAK inhibitors unless there is no other alternative.
Medscape Medical News
source https://www.medscape.com/viewarticle/most-patients-rheumatoid-arthritis-meet-european-medicines-2024a10008kq?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/most-patients-rheumatoid-arthritis-meet-european-medicines-2024a10008kq?src=rss
Comments
Post a Comment